Oncura Company Profile
On July 1, 2003, a merger between two innovative leaders in prostate cancer treatments set the standard for minimally invasive options. The merger between Amersham Health (now GE Healthcare)–Therapy Business, the leader in brachytherapy and Galil Medical’s Urology Business, the innovator in cryotherapy procedures was finalized. This formed a new company combining both our people and products enabling us to champion advances in minimally invasive prostate-cancer treatments. This new company is Oncura.Oncura has a separate and distinct identity from its parent companies and is unique in its ability to offer prostate cancer specialists the two leading minimally invasive treatment options for prostate cancer – brachytherapy and cryotherapy. Having both options in our product portfolio enables us to better meet physicians' and patients' needs
401 Plymouth Road, Suite 130
United States of America
BUSINESS WIRE --Theragenics Corporation announced it has signed a value-added loading services agreement with Oncura, a unit of GE Healthcare, to provide worldwide brachytherapy loading serv...
Theragenics Corporation® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced it has signed a value-added lo...
Drugs and Medications
On July 1, 2003, a merger between two innovative leaders in prostate cancer treatments set the standard for minimally invasive options. The merger between Amersham Health (now GE Healthcare)–Therapy...
More Information about "Oncura" on BioPortfolio
We have published hundreds of Oncura news stories on BioPortfolio along with dozens of Oncura Clinical Trials and PubMed Articles about Oncura for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oncura Companies in our database. You can also find out about relevant Oncura Drugs and Medications on this site too.